2nd Annual Quality Oversight of Clinical Vendors

The inaugural Quality Oversight of Clinical Vendors Conference in October of 2010 attracted over 100 clinical quality and operation professionals to discuss varying methods for measuring, monitoring and maintaining quality work from clinical vendors. Almost 90% of the audience included representatives from the industry’s leading pharmaceutical and biotechnology companies, who were all very open with their experiences making for a candid and highly educational exchange of lessons learned and best practices. Building on the success of the first year, the 2nd Quality Oversight of Clinical Vendors Conference provides updated presentations from several of last year’s faculty and audience members demonstrating how they successfully incorporated what they learned from the conference in addition to multiple experts that are new to the program.

Testimonials

"This was an excellent conference—very informative and useful."
Esther Timmeney, Compliance Advice and Assurance Advisor, AstraZeneca

"The conference and speakers were all excellent. This was a very valuable conference and input from the participants will improve our quality oversight of vendors."
Brandy Schenck, Auditor, Quality Assurance Infinity Pharmaceuticals

"This was one of the best I’ve attended in a long while. Interactions were excellent."
Grace Crawford, Senior Director, QA, ICON

"Excellent. Well worth the time attending. Great representation from industry for speakers—not the same old crowd."
Linda Donahoe, Director, Outsourcing and Contracts, Genzyme

"Conference was a positive open forum that provided an opportunity for sponsors and vendors to come together and share experiences, lessons learned, and identify a path to improve sponsor oversight through better channels of communication."
Maryann Livolsi, Associate Director, Global R&D Quality Assurance, Shire Pharmaceuticals

"Exceeded expectations. Excellent conference with excellent speakers. All of us learned a lot and conferences like these are what improve the drug development process."
Munish Mehra, PhD, Managing Director, Global Drug Development Experts

"This seminar was one of the best I have attended."
Joan Millsaps, Director, Business Operations & Outsourcing Management, Bristol-Myers Squibb Corporation